Neutralisation of Rivaroxaban Interference on APCR, FVIII and FIX Assays by DOAC-StoP and Andexanet ALFA

Pathology - United States
doi 10.1016/j.pathol.2020.01.374
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Coordinating Emergent Procedures After Andexanet Alfa

American Journal of Hematology
Hematology
2019English

Andexanet Alfa in the Treatment of Acute Major Bleeding Related to Apixaban and Rivaroxaban: A Profile of Its Use in the USA

Drugs and Therapy Perspectives
Pharmacology
2018English

Biotin Interference in TSH, FT4, and FT3 Assays Based on the LOCI Technology: Identifying Interference by Dilution

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Growth Hormone: Isoforms, Clinical Aspects and Assays Interference

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Determination of Rivaroxaban by Different Factor Xa Specific Chromogenic Substrate Assays: Reduction of Interassay Variability

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2011English

Norethisterone Interference in Testosterone Assays

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2014English

Generation, Lyophilisation and Epitope Modification of High Titre Filovirus Pseudotyped Lentiviruses for Use in Antibody Neutralisation Assays

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Immunoglobulin Interference in Serum Follicle-Stimulating Hormone Assays: Autoimmune and Heterophilic Antibody Interference

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2010English

Rotavirus Neutralisation by Human Milk.

BMJ
1977English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy